[Frontalis suspension using autogenous fascia lata--evaluation of long-term outcome].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Transliterated Title:
      Podwieszenie powiek górnych na paskach powiezi szerokiej uda--ocena późnych wyników.
    • Source:
      Publisher: Panstwowy Zaklad Wydawnictw Lekarskich Country of Publication: Poland NLM ID: 0376614 Publication Model: Print Cited Medium: Print ISSN: 0023-2157 (Print) Linking ISSN: 00232157 NLM ISO Abbreviation: Klin Oczna Subsets: MEDLINE
    • Publication Information:
      Publication: Warszawa : Panstwowy Zaklad Wydawnictw Lekarskich
      Original Publication: Warszawa, Państwowy Zakład Wydawnictw Lekarskich.
    • Subject Terms:
    • Abstract:
      Purpose: To evaluate long-term outcome of frontalis suspension using autogenous fascia lata (frontalis suspension - FS) which is indicated in the treatment of severe blepharoptosis with minimal levator function.
      Material and Methods: Fourty one patients (23 females, 18 males, aged 6-79 years, mean 41.4 years) who underwent FS between 1999 and 2009 were evaluated. Mean follow-up was 55 months. Functional outcome was measured on digital photographs by analysis of an upper eyelid margin position below the superior limbus. Following criteria were used: very good (< 3 mm), good (3-5 mm), unsatisfactory (> 5 mm). Aesthetic outcome was assessed in terms of lid contour, symmetry of lid height and lid crease. Patient satisfaction and life quality improvement were evaluated in the survey.
      Results: Functional outcome was very good in 36%, good in 59.3%, unsatisfactory in 4.7%. Recurrence occured in 4.6% and complications in 10.9% (lagophthalmos--6.2%, entropion--4.7%). Very good aesthetic outcome regarding lid contour, symmetry of lid height and lid crease was achieved in 76.6%, 53.6% and 51.6%, respectively. Patient satisfaction and life quality improvement was also very high. There were only 1.6% unsatisfied patients.
      Conclusions: FS is an efficient method in treatment of severe blepharoptosis.
    • Publication Date:
      Date Created: 20130205 Date Completed: 20130301 Latest Revision: 20141120
    • Publication Date:
      20221213
    • Accession Number:
      23373401